newswire, breaking biotechnology and pharma news

Monday, June 13, 2016

Marcum MicroCap Conference Showcases Technology, Biotech and Health and Wellness Companies

Marcum MicroCap Conference Showcases Technology, Biotech and Health and Wellness Companies

Point Roberts, WA, June 13, 2016 –, a global news source and investor resource covering actively traded sectors reports on the recent 5th Annual Marcum MicroCap Conference held June 1- June 2, 2016, in New York City at the Grand Hyatt Hotel.
The two- day conference presented a cross section of companies in Technology, Media & Internet, Software & Business Services, Life Science & Healthcare, Retail & Consumer Products, Energy & Natural Resources, Industrials and Financials & Asset Management Services
The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The 2016 Conference will be two full days with feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis.
Gino Pereira, Chief Executive Officer of NXT-ID, Inc. (NasdaqCM: NXTD) shows investors its payment technology portfolio including the Wocket smart wallet and the new smart card being developed for WorldVentures. The SmartCard is being customized exclusively for WorldVentures DreamTrips Members, currently numbered at over 500,000 worldwide and growing.    

Gino Pereira, Chief Executive Officer of NXT-ID, Inc.

NXT-ID, Inc. (NasdaqCM:NXTD) is an emerging growth technology company that is focused on products, solutions, and services for security on mobile devices. Our core technologies consist of those that support digital payments, biometric identification, encryption, sensors, and miniaturization. We have three distinct lines of business that we are currently pursuing: mobile commerce, primarily through the application of secure digital payment technologies; biometric access control applications, and Department of Defense contracting. Our initial efforts have primarily focused on the development of our secure products for the growing m-commerce market, most immediately, a secure mobile electronic smart wallet, the Wocket®. The Wocket® is a smart wallet, designed to protect your identity.,
Dr. Sergio Traversa PharmD, MBA, CEO  of Relmada Therapeutics (OTC:RLMD)  said at the conference, “One thing that I have learned and I am strongly convinced about I; is that to make a biotech or pharmaceutical company successful, you need three components:  you need the science, you need the capital and you need the people…and if I had to pick one of these three components to be successful, I will always give you the same answer, and it is the people.”

Mr. Denis Corin, President of Q BioMed Inc.  (OTCQB: QBIO presented his company’s mission to license and acquire innovative life sciences assets from academia or small private companies,

Mr. Denis Corin, President of Q BioMed Inc.

About Q BioMed Inc. (OTCQB: QBIO)
Q BioMed Inc. ("Q") is a biomedical acceleration and development company. We are focused on acquiring companies and biomedical assets. Q is dedicated to providing these target companies and assets, strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need.

Relmada Therapeutics (OTC:RLMD)  is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The Company has a diversified portfolio of four lead products at various stages of development including LevoCap ER, its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol; d-methadone, its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; BuTab ER, its oral dosage form of the opioid analgesic buprenorphine; and MepiGel, its orphan drug designated topical formulation of the local anesthetic mepivacaine. The Company’s product development efforts are guided by the internationally recognized scientific expertise of its research team. The Company’s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.   Investor presentation available at

Rod A. Smith, CEO/Founder of Green PolkaDot Box Incorporated (GPDB) talked about their non-GMO product lines and their goal to make healthy food affordable to America.
Green PolkaDot Box® is America's "first mover" online U.S. distributor of CLEAN foods. Green PolkaDot Box (“GPDB” or the Company), a publicly traded company (OTC: GPDB), is an online food distributor that is solving enormous food problems in the United States: (1) the high cost and limited availability of CLEAN foods; and (2) the proliferation of GMO contaminated foods that have pervaded more than 70% of the food supply.

GREEN POLKADOT BOX INCORPORATED’s mission is to educate, inform consumers about the links between a poor diet and chronic illness and disease and deliver CLEAN foods to millions of U.S. households at wholesale pricing with FREE home delivery; both services provided through a network of thousands of influential Health Merchants; and to employ sustainable business practices for a healthier America while conserving the Earth’s natural environment

Michael DePasquale CEO of BIO-key International presented his company’s biometric technology.
BIO-key (OTC: BKYI) headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world.

Some other companies presenting included: 

Tecogen Inc. (NasdaqCM:TGEN) designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including natural gas engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company is known for cost efficient, environmentally friendly and reliable products for energy production that, through patented technology, nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 20 years, Tecogen has shipped more than 2,300 units, supported by an established network of engineering, sales, and service personnel across the United States.

Coffee Holding Company, Inc. (NasdaqCM:JVA) is a leading integrated wholesale coffee roaster and dealer in the United States and one of the few coffee companies that offers a broad array of coffee products across the entire spectrum of consumer tastes, preferences and price points. Coffee Holding has been a family-operated business for three generations and has remained profitable through varying cycles in the coffee industry and the economy. The Company's private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers, and individually owned and multi-unit retail customers.

Fuling Global Inc. (NasdaqCM:FORK) is a specialized producer and distributor of environmentally friendly plastic serviceware, with precision manufacturing facilities in both the U.S. and China. The Company's plastic serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic products and are used by more than one hundred customers primarily from the U.S. and Europe, including Subway, Wendy's, Burger King, KFC (China only), Walmart, McKesson, and Woolworths.

Dataram Corporation (NasdaqCM: DRAM) is a leading independent manufacturer of memory products and provider of performance solutions that increase the performance and extend the useful life of servers, workstation, desktops and laptops sold by leading manufacturers such as Dell, Cisco, Fujitsu, HP, IBM, Lenovo and Oracle. Dataram's memory products and solutions are sold worldwide to OEMs, distributors, value-added resellers and end users. Additionally, Dataram manufactures and markets a line of Intel Approved memory products for sale to manufacturers and assemblers of embedded and original equipment. 70 Fortune 100 companies are powered by Dataram. Founded in 1967, the Company is a US based manufacturer, with presence in the United States, Europe and Asia.

IZEA Inc. (NasdaqCM: IZEA) operates IZEAx, the premier online marketplace that connects brands with influential content creators. IZEA creators range from leading bloggers and social media personalities to A-list celebrities and professional journalists. Creators are compensated for developing and distributing unique content on behalf of brands including long form text, videos, photos and status updates. Brands receive influential consumer content and engaging, shareable stories that drive awareness.

Capnia, Inc. (NasdaqCM:CAPN) is a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs. Capnia's lead commercial product, CoSense, is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. The Company's commercial, neonatology-focused product line also includes innovative pulmonary resuscitation solutions, including the NeoPIP™ Infant T-Piece Resuscitator and Universal T-Piece Circuit consumables. Serenz Allergy Relief is Capnia’s proprietary commercial product that uses nasal, non-inhaled CO2 to relieve nasal allergy symptoms such as congestion, sneezing, itchy and runny nose.  The nasal, non-inhaled CO2 therapeutic technology is also being evaluated to treat trigeminally-mediated pain conditions such as cluster headache, trigeminal neuralgia, and migraine.

Pulmatrix (NasdaqGM:PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE™ technology. The Company's proprietary product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for lung disease patients. In addition, Pulmatrix is pursuing opportunities in major pulmonary diseases through collaborations, including PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease (COPD).  Pulmatrix's product candidates are based on iSPERSE™, its proprietary dry powder delivery platform, which seeks to improve therapeutic delivery to the lungs by maximizing local concentrations and reducing systemic side effects to improve patient outcomes.

See a full list of presenting companies:

Read this release in full and view images at

About - News that Inspires Big Ideas
Sectors we cover in include mining, energy, renewable energy, water stocks, food and beverage (including organic and LOHAS, wine), defense and security, biotech, technology and mobile. We have also expanded our global coverage to include Latin American stocks, the Middle East, sports and entertainment.

Follow on Twitter!/Investorideas
Follow on Facebook

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies:

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:   Disclosure: As of October 1, 2015 NXT-Id renewed for one year –five thousand per month and fifteen thousand 144 restricted shares for PR, media and marketing . QBIO is a former advertiser /client on

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:  Global investors must adhere to regulations of each country.



1 comment:

  1. Great article, I would love to be able to sit in on that conference. Too bad its extremely difficult to get a seat.